Publications by authors named "Sherrie Kelly"

Claim this Profile
V
Value profile for Malaria vaccines and monoclonal antibodies.
Ashley J Birkett, Evelyn Ansah, Scott Gordon, Margaret Gyapong, Shanelle Hall, Sherrie L Kelly

Vaccine· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying priority populations for HIV interventions using acquisition and transmission indicators: a combined analysis of 15 mathematical models from ten African countries.
Romain Silhol, Ross D Booton, Kate M Mitchell, James Stannah, Oliver Stevens, Sherrie L Kelly

Lancet HIV· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance characteristics and potential public health impact of improved pre-erythrocytic malaria vaccines targeting childhood burden.
Josephine Malinga, Lydia Braunack-Mayer, Thiery Masserey, Aurélien Cavelan, Daniel Chandramohan, Sherrie L Kelly

PLOS Glob Public Health· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public health impact of current and proposed age-expanded perennial malaria chemoprevention: a modelling study.
Swapnoleena Sen, Lydia Braunack-Mayer, Sherrie L Kelly, Thiery Masserey, Josephine Malinga

Sci Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic development to accelerate malaria control through intentional intervention layering.
Lydia Braunack-Mayer, Narimane Nekkab, Josephine Malinga, Sherrie L Kelly, Evelyn Ansah

Malar J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimising HIV spending in 12 eastern European and central Asian countries: a modelling study.
Debra C Ten Brink, Anna L Bowring, Rowan Martin-Hughes, Nisaa Wulan, Yinzong Xiao, Sherrie L Kelly

Lancet HIV· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seasonal malaria chemoprevention and the spread of Plasmodium falciparum quintuple-mutant parasites resistant to sulfadoxine-pyrimethamine: a modelling study.
Thiery Masserey, Tamsin Lee, Sherrie L Kelly, Ian M Hastings, Melissa A Penny

Lancet Microbe· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and selection of drug properties to increase the public health impact of next-generation seasonal malaria chemoprevention: a modelling study.
Lydia Braunack-Mayer, Josephine Malinga, Thiery Masserey, Narimane Nekkab, Swapnoleena Sen, Sherrie L Kelly

Lancet Glob Health· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring HIV Acquisitions Among Partners of Key Populations: Estimates From HIV Transmission Dynamic Models.
Romain Silhol, Rebecca L Anderson, Oliver Stevens, James Stannah, Ross D Booton, Sherrie L Kelly

J Acquir Immune Defic Syndr· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public health benefits of shifting from hospital-focused to ambulatory TB care in Eastern Europe: Optimising TB investments in Belarus, the Republic of Moldova, and Romania.
Sherrie L Kelly, Gerard Joseph Abou Jaoude, Tom Palmer, Jolene Skordis, Hassan Haghparast-Bidgoli

PLOS Glob Public Health· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling to inform next-generation medical interventions for malaria prevention and treatment.
Narimane Nekkab, Josephine Malinga, Lydia Braunack-Mayer, Sherrie L Kelly, R Scott Miller

Commun Med (Lond)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of voluntary medical male circumcision for HIV prevention across sub-Saharan Africa: results from five independent models.
Loveleen Bansi-Matharu, Edinah Mudimu, Rowan Martin-Hughes, Matt Hamilton, Leigh Johnson, Sherrie L Kelly

Lancet Glob Health· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health and economic benefits of achieving contraceptive and maternal health targets in Small Island Developing States in the Pacific and Caribbean.
Sherrie L Kelly, Tom Walsh, Dominic Delport, Debra Ten Brink, Rowan Martin-Hughes

BMJ Glob Health· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent and unpredictable changes in COVID-19 policies and restrictions reduce the accuracy of model forecasts.
Farah Houdroge, Anna Palmer, Dominic Delport, Tom Walsh, Sherrie L Kelly

Sci Rep· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Vaccine Booster Strategies in Light of Emerging Viral Variants: Frequency, Timing, and Target Groups.
Sherrie L Kelly, Epke A Le Rutte, Maximilian Richter, Melissa A Penny, Andrew J Shattock

Infect Dis Ther· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models.
Anna Bershteyn, Lise Jamieson, Hae-Young Kim, Ingrida Platais, Masabho P Milali, Sherrie L Kelly

Lancet Glob Health· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of biological, epidemiological, and treatment factors on the establishment and spread of drug-resistant .
Thiery Masserey, Tamsin Lee, Monica Golumbeanu, Andrew J Shattock, Sherrie L Kelly

Elife· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burden.
Epke A Le Rutte, Andrew J Shattock, Nakul Chitnis, Sherrie L Kelly, Melissa A Penny

Commun Med (Lond)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study.
Andrew N Phillips, Anna Bershteyn, Paul Revill, Loveleen Bansi-Matharu, Katharine Kripke, Sherrie L Kelly

Lancet HIV· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness and impact of pre-exposure prophylaxis to prevent HIV among men who have sex with men in Asia: A modelling study.
Debra C Ten Brink, Rowan Martin-Hughes, Mark E Minnery, Aaron J Osborne, Heather-Marie A Schmidt, Sherrie L Kelly

PLoS One· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland.
Andrew J Shattock, Epke A Le Rutte, Robert P Dünner, Swapnoleena Sen, Sherrie L Kelly

Epidemics· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impacts of COVID-19-related service disruptions on TB incidence and deaths in Indonesia, Kyrgyzstan, Malawi, Mozambique, and Peru: Implications for national TB responses.
Rowan Martin-Hughes, Lung Vu, Nejma Cheikh, Sherrie L Kelly, Nicole Fraser-Hurt

PLOS Glob Public Health· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs and impact on HIV transmission of a switch from a criminalisation to a public health approach to injecting drug use in eastern Europe and central Asia: a modelling analysis.
Zoe Ward, Jack Stone, Chrissy Bishop, Viktor Ivakin, Ksenia Eritsyan, Sherrie L Kelly

Lancet HIV· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risks and benefits of providing HIV services during the COVID-19 pandemic.
John Stover, Sherrie L Kelly, Edinah Mudimu, Dylan Green, Tyler Smith

PLoS One· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
John Stover, Robert Glaubius, Yu Teng, Sherrie Kelly, Tim Brown

PLoS Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis